UB Paderborn / Katalog / Suche / in CDI

The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease

Frontiers in nutrition (Lausanne), 2022-04, Vol.9, p.718710-718710

2022

Link zum Volltext

Verfügbarkeit prüfen

Burnout among European IBD specialists: a survey supported by ECCO

Therapeutic advances in gastroenterology, 2023-01, Vol.16, p.17562848231214086-17562848231214086

2023

Link zum Volltext

Verfügbarkeit prüfen

Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls

Therapeutic advances in gastroenterology, 2023-01, Vol.16, p.17562848231174298-17562848231174298

2023

Link zum Volltext

Verfügbarkeit prüfen

Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients following COVID-19 vaccination

Therapeutic advances in gastroenterology, 2023-01, Vol.16, p.17562848231183529-17562848231183529

2023

Link zum Volltext

Verfügbarkeit prüfen

The complex relationship between viruses and inflammatory bowel disease – review and practical advices for the daily clinical decision-making during the SARS-CoV-2 pandemic

Therapeutic Advances in Gastroenterology, 2021, Vol.14, p.1756284820988198-1756284820988198

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of COVID-19 pandemic on the workflow of endoscopy units: an international survey

Therapeutic advances in gastroenterology, 2021-01, Vol.14, p.17562848211006678-17562848211006678

2021

Link zum Volltext

Verfügbarkeit prüfen

Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system

Therapeutic advances in gastroenterology, 2024-01, Vol.17, p.17562848241239606-17562848241239606

2024

Link zum Volltext

Verfügbarkeit prüfen

Self-reported efficacy and safety of infliximab and adalimumab biosimilars after non-medical switch in patients with inflammatory bowel disease: results of a multicenter survey

Expert opinion on biological therapy, 2023-08, Vol.ahead-of-print (ahead-of-print), p.1-6

2023

Link zum Volltext

Verfügbarkeit prüfen

Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn’s disease: results from a multicentre cohort study

Therapeutic advances in gastroenterology, 2022-01, Vol.15, p.17562848221144349-17562848221144349

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study

Inflammatory bowel diseases, 2024-05, Vol.30 (5), p.768-779

2024

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors and Interpretation of Inconclusive Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology in the Diagnosis of Solid Pancreatic Lesions

Diagnostics (Basel), 2023-09, Vol.13 (17), p.2841

2023

Link zum Volltext

Verfügbarkeit prüfen

Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases

Journal of Crohn's and colitis, 2024-03, Vol.18 (3), p.392-405

2024

Link zum Volltext

Verfügbarkeit prüfen

Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone

Expert opinion on drug safety, 2023-06, Vol.22 (6), p.517-524

2023

Link zum Volltext

Verfügbarkeit prüfen

Conception and reality: Outcome of SARS-CoV-2 infection and vaccination among Hungarian IBD patients on biologic treatments

Vaccine: X, 2023-04, Vol.13, p.100253-100253, Article 100253

2023

Link zum Volltext

Verfügbarkeit prüfen

Analysis of efficacy and safety of colonoscopic screening program at the University of Szeged and the Bács-Kiskun County Teaching Hospital between 2019 and 2022

Orvosi hetilap, 2024-02, Vol.165 (6), p.221

2024

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcomes after endoscopic removal of malignant colorectal polyps: Results from a 10-year cohort

World journal of gastrointestinal endoscopy, 2024-04, Vol.16 (4), p.193-205

2024

Link zum Volltext

Verfügbarkeit prüfen

Iron Deficiency Anemia in Inflammatory Bowel Disease: What Do We Know?

Frontiers in medicine, 2021-07, Vol.8, p.686778-686778

2021

Link zum Volltext

Verfügbarkeit prüfen

Still the Joker in the Pack: When to Take Out Cyclosporine in the Game?

Inflammatory bowel diseases, 2021-08, Vol.27 (8), p.e95-e95

2021

Link zum Volltext

Verfügbarkeit prüfen

Letter: Experience of switching vedolizumab treatment from intravenous to subcutaneous formulation in Hungary

Alimentary pharmacology & therapeutics, 2023-07, Vol.58 (2), p.262-263

2023

Link zum Volltext

Verfügbarkeit prüfen

Letter: ciclosporin and vedolizumab for steroid‐refractory ulcerative colitis

Alimentary pharmacology & therapeutics, 2020-08, Vol.52 (3), p.578-579

2020

Link zum Volltext

Verfügbarkeit prüfen

Appendiceal Mucinous Neoplasm Appearance on NBI Colonoscopy

Journal of gastrointestinal and liver diseases : JGLD, 2022-09, Vol.31 (3), p.270-270

2022

Link zum Volltext

Verfügbarkeit prüfen

Ustekinumab is associated with superior treatment persistence but not with higher remission rates vedolizumab in patients with refractory Crohn’s disease: results from a multicentre cohort study

Therapeutic advances in gastroenterology, 2022-12, Vol.15

2022

Link zum Volltext

Verfügbarkeit prüfen

Infection risk related to gastrointestinal endoscopic procedures during the SARS-CoV-2 pandemic

Orvosi hetilap, 2022-11, Vol.163 (46), p.1814

2022

Link zum Volltext

Verfügbarkeit prüfen

Endoscopic ultrasound in the lower gastrointestinal tract

Orvosi hetilap, 2023-07, Vol.164 (30), p.1176

2023

Link zum Volltext

Verfügbarkeit prüfen

The treatment of inflammatory bowel disease during the SARS-CoV-2 epidemic – practical advices: (A COVID–19-pandémia orvosszakmai kérdései)

Orvosi hetilap, 2020-06, Vol.161 (25), p.1022

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease

Burnout among European IBD specialists: a survey supported by ECCO

Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls

Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients following COVID-19 vaccination

The complex relationship between viruses and inflammatory bowel disease – review and practical advices for the daily clinical decision-making during the SARS-CoV-2 pandemic

Effect of COVID-19 pandemic on the workflow of endoscopy units: an international survey

Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system

Self-reported efficacy and safety of infliximab and adalimumab biosimilars after non-medical switch in patients with inflammatory bowel disease: results of a multicenter survey

Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn’s disease: results from a multicentre cohort study

Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study

Risk Factors and Interpretation of Inconclusive Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology in the Diagnosis of Solid Pancreatic Lesions

Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases

Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone

Conception and reality: Outcome of SARS-CoV-2 infection and vaccination among Hungarian IBD patients on biologic treatments

Analysis of efficacy and safety of colonoscopic screening program at the University of Szeged and the Bács-Kiskun County Teaching Hospital between 2019 and 2022

Long-term outcomes after endoscopic removal of malignant colorectal polyps: Results from a 10-year cohort

Iron Deficiency Anemia in Inflammatory Bowel Disease: What Do We Know?

Still the Joker in the Pack: When to Take Out Cyclosporine in the Game?

Letter: Experience of switching vedolizumab treatment from intravenous to subcutaneous formulation in Hungary

Letter: ciclosporin and vedolizumab for steroid‐refractory ulcerative colitis

Appendiceal Mucinous Neoplasm Appearance on NBI Colonoscopy

Ustekinumab is associated with superior treatment persistence but not with higher remission rates vedolizumab in patients with refractory Crohn’s disease: results from a multicentre cohort study

Infection risk related to gastrointestinal endoscopic procedures during the SARS-CoV-2 pandemic

Endoscopic ultrasound in the lower gastrointestinal tract

The treatment of inflammatory bowel disease during the SARS-CoV-2 epidemic – practical advices: (A COVID–19-pandémia orvosszakmai kérdései)

Suchergebnisse filtern